Magnetic resonance (MR) enteroclysis imaging is emerging as a technique for
evaluation of the small bowel in patients with Crohn disease. Administrati
on of 1.5-2 L of isosmotic water solution through a naso-jejunal catheter e
nsures distention of the bowel and facilitates identification of wall abnor
malities. True fast imaging with steady-state precession (FISP), half-Fouri
er acquisition single-shot turbo spin-echo (HASTE), and postgadolinium T1 -
weighted three-dimensional fast low-angle shot sequences can be employed in
a comprehensive and integrated MR enteroclysis examination protocol to ove
rcome specific disadvantages of each of the sequences involved. Superficial
abnormalities that are ideally delineated with conventional enteroclysis a
re not consistently depicted with MR enteroclysis. The characteristic trans
mural abnormalities of Crohn disease such as bowel wall thickening, linear
ulcers, and cobblestoning are accurately shown with MR enteroclysis imaging
, especially with the true FISP sequence. MR enteroclysis is comparable to
conventional enteroclysis in the detection of the number and extent of invo
lved small bowel segments and in the disclosure of luminal narrowing or pre
stenotic intestinal dilatation. The clinical utility of MR enteroclysis in
Crohn disease has not been fully established. At present, the method may be
used for follow-up studies of known disease, estimation of disease activit
y, and determination of the extramucosal extent and spread of the disease p
rocess.